Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert G Will

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
British Medical Bulletin|October 3, 2003
Acquired prion disease: iatrogenic CJD, variant CJD, kuruRobert G Will
Swiss Medical Weekly|December 31, 2015
The end of the BSE saga: do we still need surveillance for human prion diseases?Herbert Budka, Robert G Will
Comptes Rendus Biologies|February 28, 2002
Predicting the size of the vCJD epidemic in FranceAnnick Alpérovitch, Robert G Will
Cold Spring Harbor Perspectives in Medicine|October 30, 2016
Sporadic and Infectious Human Prion DiseasesRobert G Will, James W Ironside
Journal of the Royal Society, Interface|February 9, 2007
Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?Paul Clarke, Robert G Will, Azra C Ghani
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2010
Defining sporadic Creutzfeldt-Jakob disease strains and their transmission propertiesMatthew T Bishop, Robert G Will, Jean C Manson
BMJ (Clinical Research Ed.)|June 22, 2002
First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological featuresMichael D Spencer, Richard S G Knight, Robert G Will
Emerging Infectious Diseases|October 24, 2007
Source of variant Creutzfeldt-Jakob disease outside United KingdomPascual Sanchez-Juan, Simon N Cousens, Robert G Will, et al.
Health & Social Care in the Community|July 18, 2002
Variant Creutzfeldt-Jakob disease: costs borne by familiesSusan Myles, Margaret J Douglas, Hester J T Ward, et al.
Neuroepidemiology|March 21, 2009
Survival and re-operation rates after neurosurgical procedures in Scotland: implications for targeted surveillance of sub-clinical variant Creutzfeldt-Jakob diseaseSheila M Bird, Elizabeth L C Merrall, Hester J T Ward, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
British Medical Bulletin|October 3, 2003
Acquired prion disease: iatrogenic CJD, variant CJD, kuruRobert G Will
Swiss Medical Weekly|December 31, 2015
The end of the BSE saga: do we still need surveillance for human prion diseases?Herbert Budka, Robert G Will
Comptes Rendus Biologies|February 28, 2002
Predicting the size of the vCJD epidemic in FranceAnnick Alpérovitch, Robert G Will
Cold Spring Harbor Perspectives in Medicine|October 30, 2016
Sporadic and Infectious Human Prion DiseasesRobert G Will, James W Ironside
Journal of the Royal Society, Interface|February 9, 2007
Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?Paul Clarke, Robert G Will, Azra C Ghani
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2010
Defining sporadic Creutzfeldt-Jakob disease strains and their transmission propertiesMatthew T Bishop, Robert G Will, Jean C Manson
BMJ (Clinical Research Ed.)|June 22, 2002
First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological featuresMichael D Spencer, Richard S G Knight, Robert G Will
Emerging Infectious Diseases|October 24, 2007
Source of variant Creutzfeldt-Jakob disease outside United KingdomPascual Sanchez-Juan, Simon N Cousens, Robert G Will, et al.
Health & Social Care in the Community|July 18, 2002
Variant Creutzfeldt-Jakob disease: costs borne by familiesSusan Myles, Margaret J Douglas, Hester J T Ward, et al.
Neuroepidemiology|March 21, 2009
Survival and re-operation rates after neurosurgical procedures in Scotland: implications for targeted surveillance of sub-clinical variant Creutzfeldt-Jakob diseaseSheila M Bird, Elizabeth L C Merrall, Hester J T Ward, et al.
Pageof 5